Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.73 CAD | -0.84% | +1.72% | +19.75% |
08/04 | HLS Therapeutics Inc. Announces Reduce-IT Analysis Results Relating the Effects of VASCEPA | CI |
14/03 | Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.75% | 111M | |
+17.88% | 70.09B | |
-1.07% | 24.01B | |
+8.01% | 8.32B | |
-18.28% | 8.23B | |
0.00% | 8.08B | |
+4.40% | 4.68B | |
+16.55% | 4.41B | |
-0.70% | 4.12B | |
-2.20% | 3.88B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- HLS Therapeutics Establishes Automatic Share Purchase Plan